Free Stock Tips

Hello All,

What a month!

Another 100% price gain today !!

When we said we’re big fans of September, we weren’t lying.

Since today’s holding company did so well we thought we would bring you another.

Let’s keep the streak of winners going!!

This one acquires companies offering in demand medical solutions.

Today they just announced their first acquisition!

They have acquired a technology which is a solution for a problem facing 5.5 million Americans annually!

Our alert for Thursday is Allzoe Medical Holdings, Inc., ALZM, and the stock closed Wednesday at 62 cents.

ALZM is a holding company focused on acquiring the most high-quality and in demand medical products, solutions and services.

ALZM announced today that they are acquiring technology that enables healthcare providers to “see and treat” the most common sexually transmitted infection and a cause of cervical cancer, Human Papillomavirus (HPV).

ALZM acquired the patent pending technology from Aequorea Vision Medical, based in Texas, in the deal ALZM also acquires all related intellectual property as well as the existing prototype models of the device.

ALZM plans to form a new wholly-owned subsidiary to complete the development of the device, obtain the required regulatory approvals and clearances, and begin marketing the device and technology.

The light-based exam device ALZM is acquiring instantly identifies HPV lesions with 98% accuracy, enabling providers to see cell damage and then treat the patient on the spot.

ALZM’s technology also offers an important alternative to the HPV vaccine.

ALZM will be solving a very big problem. Prominent figures, most recently two U.S. Presidential candidates, have taken firm (and opposing) public stances, further highlighting the ongoing controversy about the HPV vaccine. For other reasons, including the vaccine’s cost and the inconvenience of it being administered over a number of visits, many patients don’t actually complete the series. Last year only 32 percent of teenage girls nationwide received all three shots needed to prevent HPV infection.

ALZM’s technology could be the solution!

HPV is the most common sexually transmitted infection.
Approximately 20 million Americans are infected with HPV and it is expected that 5.5 million will contract the HPV through sexual contact each year.

According to Time.com, approximately 40% of girls become infected with HPV within two years of becoming sexually active. By age 50, 80% of women have had the virus at some point, though many have no symptoms. While asymptomatic patients may not know to seek treatment, the technology, which can be incorporated into a regular visit, will allow healthcare staff to identify a problem before it becomes more serious. Currently, HPV causes 70% of cervical cancer cases; cervical cancer is diagnosed in 11,000 women per year in the U.S. alone.

ALZM’s technology could be a solution to one of America’s largest and fastest growing medical problems.

ALZM is beginning to become active, as it looks like investors are starting to learn their story.

The more exposure ALZM receives, the more people hear about this great story. You guys are some of the first to hear about this company, and that definitely gives you an advantage at being able to profit on it.

ALZM belongs on your watchlist for Thursday.

As always, do your own research, always use stop loss orders to protect yourself, and book your profits when in a position to do so.

Good Trading